Select Page


For information on migraine clinical trials, please contact Maxime Boutin-Caron.

Current Recruiting Studies

There are no recruiting studies at the moment.

Active Studies (not recruiting)

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients with Chronic Migraine – the REGAIN Study


The main purpose of this study is to evaluate the efficacy of the study drug known as galcanezumab in participants with chronic migraine.

More information

Multi-Centre, Prospective, Observational Study of Patient Reported Outcomes in Patients Diagnosed with Chronic Migraine and treated with OnabotulinumtoxinA for injection (BOTOX®)


This study will prospectively assess long term heath related quality of life in chronic migraine patients currently being treated with OnabotulinumtoxinA for injection (BOTOX®) as standard of care.

More information